Modus Therapeutics Holding AB
556851-9523ActiveSwedish biotech developing sevuparin for severe inflammatory conditions.
Oversikt
- 1–4
- Ansatte
- 500–749t SEK
- Omsetning
- 2011
- Grunnlagt
Nøkkelbeslutningstakere
John Öhd
Chief Executive Officer
Johan Dighed
Board member
Viktor Drvota
Chairman
Michael Forer
Member of the Nomination Committee
+3 flere kontakter i Funnelfeedr
Beskrivelse
Modus Therapeutics is a Swedish biotechnology company focused on developing novel treatments for severe medical conditions. Their primary focus is the development of their proprietary polysaccharide, sevuparin. Sevuparin is being investigated as a potential therapeutic agent for several high unmet m...
Tagger
Nøkkelord
Teknologier i bruk
Bedriftsinformasjon
- Bransje
- Konsultverksamhet avseende företags organisation
- Juridisk form
- Aktiebolag
- MVA-nummer
- SE556851952301
Beslutningstakere
7 kontakter i FunnelfeedrJohn Öhd
Chief Executive Officer
Johan Dighed
Board member
Viktor Drvota
Chairman
Michael Forer
Member of the Nomination Committee
Ellen Donnelly
Board Member
Claes Lindblad
CFO & Head of IR
Ellen K. Donnelly
Board Member
Lignende bedrifter
20 lignende bedrifter i FunnelfeedrSangair AB
3 ansatteDeveloping revolutionary blood treatment technology to combat severe sepsis infections.
Aptahem AB
0 ansatteBiotech company developing RNA therapeutics for acute inflammatory diseases like sepsis.
Kyowa Kirin International NewCo Sweden AB
Global specialty pharmaceutical company focused on innovative drug development.
ZEALAND PHARMA A/S
0 ansatteDeveloping peptide medicines for metabolic health challenges globally.
Disruptive Pharma AB (publ)
5–9 ansatteSwedish biotech developing novel kidney disease therapies based on proprietary peptides.
Utforsk mer
Spørsmål om Modus Therapeutics Holding AB
Vil du se Funnelfeedr i aksjon?
Book en gratis demo og oppdag hvordan Funnelfeedr hjelper deg med å finne og konvertere dine ideelle kunder.
Book en demo